Zhejiang Pharmaceutical is a prominent joint-stock pharmaceutical company that emphasizes innovation and research in its operations. The company boasts a robust research and development (R&D) framework, highlighted by its impressive portfolio of 563 domestic invention patents and 164 international invention patents. This commitment to R&D is further demonstrated through initiatives such as the advanced seminar on "Innovative Drug R&D and Research on Key Technologies of Chemical Drugs," which showcases the company's focus on enhancing scientific research capabilities and accelerating technological advancements in the pharmaceutical sector.

In addition to its R&D efforts, Zhejiang Pharmaceutical is dedicated to social responsibility and community support, as evidenced by its significant donations during health crises, such as the COVID-19 pandemic. The company has actively contributed to epidemic relief efforts, donating millions in medicines and financial support to affected areas. This dual focus on technological innovation and social responsibility underscores Zhejiang Pharmaceutical's commitment to not only advancing medical science but also positively impacting public health and welfare.

China

Zhejiang Medicine Co.,Ltd founded in 1954. currently has nine major subsidiaries and two research units.The company has more than 6,800 employees, including more than 2,500 professional and technical personnel, who account for more than 37% of the company’s total number of employees.

Zhejiang Medicine performs the specialized and large-scale production of fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products. The company's leading products, including its synthetic Vitamin E, natural Vitamin E, β-carotene,Lutein, Fish oil(Omega-3) etc.,

Zhejiang Pharmaceutical

Company Details